Your browser doesn't support javascript.
loading
ß-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models.
Ganesh, Shanthi; Shui, Xue; Craig, Kevin P; Koser, Martin L; Chopda, Girish R; Cyr, Wendy A; Lai, Chengjung; Dudek, Henryk; Wang, Weimin; Brown, Bob D; Abrams, Marc T.
Afiliação
  • Ganesh S; Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts. sganesh@dicerna.com.
  • Shui X; Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts.
  • Craig KP; Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts.
  • Koser ML; Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts.
  • Chopda GR; Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts.
  • Cyr WA; Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts.
  • Lai C; Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts.
  • Dudek H; Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts.
  • Wang W; Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts.
  • Brown BD; Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts.
  • Abrams MT; Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts.
Mol Cancer Ther ; 17(2): 544-553, 2018 02.
Article em En | MEDLINE | ID: mdl-29282298

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridonas / Pirimidinonas / RNA Mensageiro / Neoplasias Colorretais / MAP Quinase Quinase Quinases / RNA Interferente Pequeno / Beta Catenina Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridonas / Pirimidinonas / RNA Mensageiro / Neoplasias Colorretais / MAP Quinase Quinase Quinases / RNA Interferente Pequeno / Beta Catenina Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article